Bariatric Surgery Can Lead to Diabetes Remission, Cut Cancer Risk
Patients with obesity and type 2 diabetes who underwent bariatric surgery and had 10-year durable diabetes remission had a 60% lower risk of incident cancer than patients who had usual obesity care. And women who had bariatric surgery had a 42% lower risk of having cancer during a median 21-year follow-up, compared to women who had usual obesity care. These findings from 701 patients in the Swedish Obese Subjects (SOS) Study who had type 2 diabetes were recently published in Diabetes Care. The results illustrate the "connection between glucose control and cancer prevention" and suggest that "among patients with type 2 diabetes, many cancer cases are preventable," lead author Kajsa Sjöholm, PhD, associate professor of molecular medicine at Sahlgrenska Academy, University of Gothenburg, Sweden, said in a press release from the university.
@harry It is well established that obesity is a risk factor for 13 types of cancer, and some of these cancers (liver, pancreatic, endometrial, colon and rectal, breast, and bladder) may be related to type 2 diabetes. And bariatric surgery has been shown to reduce cancer risk in patients with obesity. However, it is not clear how bariatric surgery may affect cancer risk in patients with obesity and type 2 diabetes. To study this, the researchers examined data from 393 patients who underwent bariatric surgery and 308 patients who received usual obesity treatment, who were part of the SOS study. The SOS study enrolled men with a body mass index (BMI) ≥ 34 kg/m2, and women with a BMI ≥ 38 kg/m2 who were 37 to 60 years old, between 1987 to 2001. The current study outcome — cancer incidence in patients with obesity and type 2 diabetes — was not a prespecified outcome